The use of the endothelin receptor antagonist, Tezosentan, before or after renal ischemia protects renal function

Transplantation

Volumn 71, Issue 2, 2001, Pages 211-216

  Wilhelm, S M ^a   Stowe, N T ^a   Robinson, A V ^a   Schulak, J A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENDOTHELIN RECEPTOR ANTAGONIST; INULIN; TEZOSENTAN; UNCLASSIFIED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; INULIN CLEARANCE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE EPITHELIUM; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 0035956718     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200101270-00007     Document Type: Article

References (30)

1. Strategy for eliminating the kidney shortage
2. Update in transplantation - 1997
3. The asystolic, or non-heart-beating, donor
4. Transplantation of kidneys from donors whose hearts have stopped beating
5. Procurement and allocation of solid organs for transplantation
6. Early risk factors contributing to the evolution of long-term allograft dysfunction
7. Delayed graft function in renal transplantation: Etiology, management and long-term significance
8. The "injury response": A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes
9. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
10. Glomerular actions of endothelin in vivo
11. Pathophysiological role of endothelin in acute renal failure
12. Endothelin up-regulation and localization following renal ischemia and reperfusion
13. Cold ischemia induces endothelin gene upregulation in the preserved kidney
14. 2 in cold storage can reveal previous ischemic insults
15. Endothelins in the kidney: Physiology and pathophysiology
16. Endothelin
17. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation
18. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney
19. Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists
20. Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat
21. Nonpeptide endothelin receptor antagonists. V. Prevention and reversal of acute renal failure in the rat by SB 209670
22. Cost analysis of transplantation with ischemically damaged kidneys: Preliminary results
23. Effect of an endothelin-receptor antagonist on ischemic acute renal failure
24. Distribution of endothelin immunoreactivity in human kidney correlates with antemortem acute renal failure: A possible postmortem immunohistochemical test
25. Statement on non-heart-beating donor programs
26. Categories of non-heart-beating donors
27. Successful transplantation of kidneys harvested from cadaver donors at 71 to 259 minutes following cardiac arrest
28. Viability assessment of non-heart-beating donor kidneys during machine preservation
29. Transplantation of kidneys from non-heart-beating donors: An update
30. Retrospective analysis of the outcome of transplantation of non-heart-beating donor kidneys